Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Mar-21 5:35 PM View:  | McLaughlin Gerald W. Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 270,171 | -- | -- | (100%) 270.17K to 0 | |
| 19-Mar-21 5:32 PM View: | Fong Bryant Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 24,953 | -- | -- | (100%) 24.95K to 0 | |
| 19-Mar-21 5:04 PM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 126,245 | -- | -- | (100%) 126.25K to 0 | |
| 19-Mar-21 5:31 PM View: | Szyper Linda M Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
| 19-Mar-21 5:33 PM View: | Schmid John P. Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
| 19-Mar-21 6:26 PM View: | Limongelli John M SVP & General Counsel | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 83,015 | -- | -- | (100%) 83.02K to 0 | |
| 19-Mar-21 5:05 PM View: | Heller Alan L Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 446,819 | -- | -- | (100%) 446.82K to 0 | |
| 19-Mar-21 5:34 PM View: | Hecht Beth Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
| 19-Mar-21 5:36 PM View: | Robinson James A. Jr. Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
| 19-Mar-21 5:23 PM View: | Robitaille Gregory J Director | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 79,130 | -- | -- | (100%) 79.13K to 0 | |
| 16-Mar-21 8:51 AM View: | McLaughlin Gerald W. Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 02-Mar-21 | Payment of Exercise | 44,329 | $0.84 | $37,413.70 | (14%) 314.5K to 270.17K | (38%) |
| 16-Mar-21 8:49 AM View: | Limongelli John M SVP & General Counsel | Neos Therapeutics, Inc. (NEOS) | 02-Mar-21 | Payment of Exercise | 16,985 | $0.84 | $14,335.30 | (17%) 100.0K to 83.02K | (38%) |
| 16-Mar-21 8:49 AM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 02-Mar-21 | Payment of Exercise | 14,825 | $0.84 | $12,512.30 | (11%) 141.07K to 126.25K | (38%) |
| 16-Mar-21 8:49 AM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 01-Mar-21 | Payment of Exercise | 1,390 | $0.88 | $1,227.37 | (< 1%) 142.46K to 141.07K | (32%) |
| 11-Jun-20 8:24 PM View: | Schmid John P. Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
| 11-Jun-20 8:22 PM View: | Hecht Beth Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
| 11-Jun-20 8:23 PM View: | Robitaille Gregory J Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 42% 55.68K to 79.13K | |
| 11-Jun-20 8:23 PM View: | Robinson James A. Jr. Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
| 11-Jun-20 8:21 PM View: | Fong Bryant Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 1564% 1.5K to 24.95K | |
| 11-Jun-20 8:22 PM View: | Heller Alan L Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 6% 423.37K to 446.82K | |
| 11-Jun-20 8:24 PM View: | Szyper Linda M Director | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
| 04-Mar-20 5:23 PM View: | Limongelli John M SVP & General Counsel | Neos Therapeutics, Inc. (NEOS) | 02-Mar-20 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 04-Mar-20 5:22 PM View: | McLaughlin Gerald W. Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 02-Mar-20 | Grant | 290,000 | -- | -- | 1184% 24.5K to 314.5K | |
| 13-Dec-18 4:08 PM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 12-Dec-18 | Market Purchase | 5,000 | $2.16 | $10,819.50 | 13% 37.46K to 42.46K | (44%) |
| 10-Dec-18 4:04 PM View: | McLaughlin Gerald W. Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 06-Dec-18 | Market Purchase | 17,097 | $2.11 | $36,119.10 | 231% 7.4K to 24.5K | (43%) |
| 07-Dec-18 6:05 PM View: | McLaughlin Gerald W. Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 04-Dec-18 | Market Purchase | 7,403 | $2.04 | $15,119.90 | 100% 0 to 7.4K | (41%) |
| 08-Nov-18 4:19 PM View: | Heller Alan L Director | Neos Therapeutics, Inc. (NEOS) | 08-Nov-18 | Private Purchase | 43,478 | $2.30 | $99,999.40 | 11% 379.89K to 423.37K | |
| 02-May-18 8:29 PM View: | McDonnell Thomas P Chief Commercial Officer | Neos Therapeutics, Inc. (NEOS) | 01-May-18 | Payment of Exercise | 886 | $8.30 | $7,353.80 | (2%) 36.75K to 35.86K | 85% |
| 05-Mar-18 5:17 PM View: | McDonnell Thomas P Chief Commercial Officer | Neos Therapeutics, Inc. (NEOS) | 01-Mar-18 | Grant | 18,750 | -- | -- | 104% 18.0K to 36.75K | |
| 05-Mar-18 5:15 PM View: | Garg Vipin K Chief Executive Officer | Neos Therapeutics, Inc. (NEOS) | 01-Mar-18 | Grant | 25,000 | -- | -- | 18% 135.75K to 160.75K | |
| 05-Mar-18 5:14 PM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 01-Mar-18 | Grant | 18,750 | -- | -- | 100% 18.71K to 37.46K | |
| 05-Mar-18 5:16 PM View: | Engelking Dorothy VP, Regulatory Affairs | Neos Therapeutics, Inc. (NEOS) | 01-Mar-18 | Grant | 3,750 | -- | -- | 56% 6.67K to 10.42K | |
| 17-Oct-17 4:15 PM View: | Garg Vipin K Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 16-Oct-17 | Payment of Exercise | 14,895 | $8.00 | $119,160.00 | (10%) 150.64K to 135.75K | 85% |
| 02-May-17 9:09 PM View: | McDonnell Thomas P Chief Commercial Officer | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 15,000 | -- | -- | 500% 3.0K to 18.0K | |
| 02-May-17 9:09 PM View: | Garg Vipin K Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 25,000 | -- | -- | 20% 125.64K to 150.64K | |
| 02-May-17 9:09 PM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 15,000 | -- | -- | 404% 3.71K to 18.71K | |
| 02-May-17 9:10 PM View: | Engelking Dorothy VP, Regulatory Affairs | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 6,250 | -- | -- | 1502% 0.42K to 6.67K | |
| 02-May-17 9:09 PM View: | Martens Juergen Chief Tech/Operations Officer | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 15,000 | -- | -- | 150% 10.0K to 25.0K | |
| 18-Oct-16 4:23 PM View: | Garg Vipin K Chief Executive Officer Director | Neos Therapeutics, Inc. (NEOS) | 17-Oct-16 | Payment of Exercise | 9,709 | $6.37 | $61,846.30 | (7%) 135.35K to 125.64K | 81% |
| 31-Aug-16 6:43 PM View: | Fong Bryant Director | Neos Therapeutics, Inc. (NEOS) | 31-Aug-16 | Market Purchase | 1,500 | $6.54 | $9,810.00 | 100% 0 to 1.5K | (81%) |
| 25-Aug-16 4:34 PM View: | Eisenstadt Richard I Chief Financial Officer | Neos Therapeutics, Inc. (NEOS) | 25-Aug-16 | Market Purchase | 3,710 | $6.82 | $25,283.70 | 100% 0 to 3.71K | (82%) |
| 14-Jun-16 4:25 PM View: | Martens Juergen Chief Tech/Operations Officer | Neos Therapeutics, Inc. (NEOS) | 13-Jun-16 | Market Purchase | 10,000 | $9.90 | $99,000.00 | 100% 0 to 10.0K | (88%) |
| 19-May-16 5:27 PM View: | Heller Alan L Director | Neos Therapeutics, Inc. (NEOS) | 19-May-16 | Market Purchase | 10,000 | $7.61 | $76,100.00 | 3% 369.89K to 379.89K | (84%) |
| 19-May-16 5:27 PM View: | McDonnell Thomas P Chief Commercial Officer | Neos Therapeutics, Inc. (NEOS) | 19-May-16 | Market Purchase | 3,000 | $7.56 | $22,671.00 | 100% 0 to 3.0K | (84%) |
| 19-May-16 5:25 PM View: | Robitaille Gregory J Director | Neos Therapeutics, Inc. (NEOS) | 18-May-16 | Market Purchase | 7,442 | $7.55 | $56,149.90 | 15% 48.23K to 55.68K | (84%) |
| 20-Apr-16 5:12 PM View: | Cmea Ventures Vii Lp 10% Owner | Neos Therapeutics, Inc. (NEOS) | 20-Apr-16 | Market Sale | 8,327 | $9.88 | $82,304.90 | (< 1%) 1.61M to 1.6M | 88% |
| 20-Apr-16 5:12 PM View: | Cmea Ventures Vii Lp 10% Owner | Neos Therapeutics, Inc. (NEOS) | 20-Apr-16 | Market Sale | 213 | $9.88 | $2,105.31 | (< 1%) 1.6M to 1.6M | 88% |
| 20-Apr-16 5:12 PM View: | Cmea Ventures Vii Lp 10% Owner | Neos Therapeutics, Inc. (NEOS) | 19-Apr-16 | Market Sale | 7,097 | $10.03 | $71,175.80 | (< 1%) 1.62M to 1.61M | 88% |
| 20-Apr-16 5:12 PM View: | Cmea Ventures Vii Lp 10% Owner | Neos Therapeutics, Inc. (NEOS) | 19-Apr-16 | Market Sale | 182 | $10.03 | $1,825.28 | (< 1%) 1.61M to 1.61M | 88% |
| 20-Apr-16 5:12 PM View: | Cmea Ventures Vii Lp 10% Owner | Neos Therapeutics, Inc. (NEOS) | 18-Apr-16 | Market Sale | 114 | $10.10 | $1,151.35 | (< 1%) 1.62M to 1.62M | 88% |
